S. Leigh Verbois

1.8k total citations · 2 hit papers
9 papers, 1.1k citations indexed

About

S. Leigh Verbois is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Leigh Verbois has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Leigh Verbois's work include Nicotinic Acetylcholine Receptors Study (4 papers), Photoreceptor and optogenetics research (3 papers) and Renal cell carcinoma treatment (2 papers). S. Leigh Verbois is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (4 papers), Photoreceptor and optogenetics research (3 papers) and Renal cell carcinoma treatment (2 papers). S. Leigh Verbois collaborates with scholars based in United States. S. Leigh Verbois's co-authors include Robert Justice, Richard Pazdur, Edwin P. Rock, Ramzi Dagher, David E. Morse, Vicki Goodman, Donna A. Volpe, Thomas Colatsky, Anne‐Marie Tobin and Robert Parker and has published in prestigious journals such as Clinical Cancer Research, Neuroscience and Neuropharmacology.

In The Last Decade

S. Leigh Verbois

9 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma

2007 407 citations Vicki Goodman, Edwin P. Rock et al. Clinical Cancer Research profile →
Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs

2011 315 citations Donna A. Volpe, Anne‐Marie Tobin et al. Regulatory Toxicology and Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Leigh Verbois United States	8	406	269	248	146	114	9	1.1k
Peter Zannikos United States	19	215 0.5×	170 0.6×	204 0.8×	43 0.3×	71 0.6×	57	1.0k
Jens Standop Germany	23	599 1.5×	306 1.1×	635 2.6×	35 0.2×	44 0.4×	65	1.7k
Christine Alvey United States	22	268 0.7×	107 0.4×	259 1.0×	61 0.4×	68 0.6×	46	1.4k
Karen J. Klamerus United States	17	500 1.2×	382 1.4×	347 1.4×	62 0.4×	20 0.2×	41	1.3k
H. Barth Germany	25	594 1.5×	179 0.7×	75 0.3×	77 0.5×	169 1.5×	72	1.6k
Edward L. Posvar United States	16	547 1.3×	51 0.2×	414 1.7×	60 0.4×	75 0.7×	30	1.7k
Kevin T. Nguyen United States	18	307 0.8×	166 0.6×	390 1.6×	87 0.6×	23 0.2×	40	1.3k
Gordon Loewen United States	13	381 0.9×	49 0.2×	140 0.6×	35 0.2×	52 0.5×	38	861
Pritha Bhadra United States	7	140 0.3×	139 0.5×	256 1.0×	35 0.2×	27 0.2×	9	1.1k
Markus Jerling Sweden	20	283 0.7×	94 0.3×	235 0.9×	59 0.4×	11 0.1×	44	1.3k

Countries citing papers authored by S. Leigh Verbois

Since Specialization

Citations

This map shows the geographic impact of S. Leigh Verbois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Leigh Verbois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Leigh Verbois more than expected).

Fields of papers citing papers by S. Leigh Verbois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Leigh Verbois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Leigh Verbois. The network helps show where S. Leigh Verbois may publish in the future.

Co-authorship network of co-authors of S. Leigh Verbois

This figure shows the co-authorship network connecting the top 25 collaborators of S. Leigh Verbois. A scholar is included among the top collaborators of S. Leigh Verbois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Leigh Verbois. S. Leigh Verbois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Volpe, Donna A., Anne‐Marie Tobin, R. Daniel Mellon, et al.. (2011). Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs. Regulatory Toxicology and Pharmacology. 59(3). 385–390. 315 indexed citations breakdown →

2.

Malik, Shakun, Ke Liu, Qiang Xu, et al.. (2010). Folotyn (Pralatrexate Injection) for the Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma: U.S. Food and Drug Administration Drug Approval Summary. Clinical Cancer Research. 16(20). 4921–4927. 38 indexed citations

3.

Rosenfeldt, Hans, et al.. (2010). Regulatory aspects of oncology drug safety evaluation: Past practice, current issues, and the challenge of new drugs. Toxicology and Applied Pharmacology. 243(2). 125–133. 5 indexed citations

4.

Rock, Edwin P., Vicki Goodman, S. Leigh Verbois, et al.. (2007). Food and Drug Administration Drug Approval Summary: Sunitinib Malate for the Treatment of Gastrointestinal Stromal Tumor and Advanced Renal Cell Carcinoma. The Oncologist. 12(1). 107–113. 207 indexed citations

5.

Goodman, Vicki, Edwin P. Rock, Ramzi Dagher, et al.. (2007). Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma. Clinical Cancer Research. 13(5). 1367–1373. 407 indexed citations breakdown →

6.

Verbois, S. Leigh. (2003). Chronic nicotine treatment attenuates α7 nicotinic receptor deficits following traumatic brain injury. Neuropharmacology. 44(2). 224–233. 35 indexed citations

7.

Verbois, S. Leigh, Deann M. Hopkins, Stephen W. Scheff, & James R. Pauly. (2003). Chronic intermittent nicotine administration attenuates traumatic brain injury-induced cognitive dysfunction. Neuroscience. 119(4). 1199–1208. 45 indexed citations

8.

Verbois, S. Leigh, Stephen W. Scheff, & James R. Pauly. (2002). Time-Dependent Changes in Rat Brain Cholinergic Receptor Expression after Experimental Brain Injury. Journal of Neurotrauma. 19(12). 1569–1585. 45 indexed citations

9.

Verbois, S. Leigh, Patrick G. Sullivan, Stephen W. Scheff, & James R. Pauly. (2000). Traumatic Brain Injury Reduces Hippocampal α7 Nicotinic Cholinergic Receptor Binding. Journal of Neurotrauma. 17(11). 1001–1011. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact